These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26727036)

  • 1. An overview of molecular hybrids in drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2016; 11(3):281-305. PubMed ID: 26727036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the development of hybrid anticancer drugs.
    Fortin S; Bérubé G
    Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances (2015-2016) in anticancer hybrids.
    Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
    Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal Anticancer Metabolites: Synthesis Towards Drug Discovery.
    Barbero M; Artuso E; Prandi C
    Curr Med Chem; 2018; 25(2):141-185. PubMed ID: 28494746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities.
    Lourenço AM; Ferreira LM; Branco PS
    Curr Pharm Des; 2012; 18(26):3979-4046. PubMed ID: 22632756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018.
    Liu W; Li Q; Hu J; Wang H; Xu F; Bian Q
    Bioorg Med Chem; 2019 Dec; 27(23):115150. PubMed ID: 31635893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural modification of natural products for novel drug discovery.
    Yao H; Liu J; Xu S; Zhu Z; Xu J
    Expert Opin Drug Discov; 2017 Feb; 12(2):121-140. PubMed ID: 28006993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Big data' approaches for novel anti-cancer drug discovery.
    Benstead-Hume G; Wooller SK; Pearl FMG
    Expert Opin Drug Discov; 2017 Jun; 12(6):599-609. PubMed ID: 28462602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
    Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
    Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
    Kumar D; Jain SK
    Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products and their analogues as efficient anticancer drugs.
    Coseri S
    Mini Rev Med Chem; 2009 May; 9(5):560-71. PubMed ID: 19456286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
    Catanzaro E; Calcabrini C; Turrini E; Sestili P; Fimognari C
    Expert Opin Ther Targets; 2017 Aug; 21(8):781-793. PubMed ID: 28675319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
    Decker M
    Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?
    Shalini ; Kumar V
    Expert Opin Drug Discov; 2021 Apr; 16(4):335-363. PubMed ID: 33305635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs.
    Pinto DCGA; Silva AMS
    Curr Top Med Chem; 2017; 17(29):3190-3198. PubMed ID: 29243581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.